Trial intelligence / Profile preview

Aminophylline vs caffeine for osteopenia of prematurity in preterm newborns

IRCT201312163915N10Phase 3Completed

Sponsor
Research Deputy of Tabriz University of Medical Sciences
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of aminophylline and caffeine in osteopenia of prematurity (MBD) (2 arms), sponsored by Research Deputy of Tabriz University of Medical Sciences. Started Dec 2013; status: completed.

02

Drugs

aminophyllinecaffeine
03

Conditions

osteopenia of prematurity (MBD)

Beyond the preview

Go deeper on IRCT201312163915N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201312163915N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call